Zobrazeno 1 - 10 of 301 pro vyhledávání: '"Pr, Harrigan"'
4
Calibration and accuracy of the geno2pheno co-receptor algorithm for predicting HIV tropism for single and triplicate measurements of V3 genotype
Autor: David J.H.F. Knapp, LC Swenson, PR Harrigan
Publikováno v: Journal of the International AIDS Society
Background: The geno2pheno algorithm (g2p) can give dichotomous tropism based on a selectable "false positive rate" (FPR), reflecting the proportion of individuals inappropriately called "non-R5" and falsely excluded from taking CCR5 antagonists. The
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8b361990d6d524185d2038bc4555460
Zobrazit plný text záznamu
5
Correction: An activator of G protein-coupled receptor and MEK1/2-ERK1/2 signaling inhibits HIV-1 replication by altering viral RNA processing.
Autor: Wong RW, Balachandran A, Cheung PK, Cheng R, Pan Q, Stoilov P, Harrigan PR, Blencowe BJ, Branch DR, Cochrane A
Publikováno v: PLoS pathogens [PLoS Pathog] 2024 Apr 09; Vol. 20 (4), pp. e1012155. Date of Electronic Publication: 2024 Apr 09 (Print Publication: 2024).
Zobrazit plný text záznamu
6
Akademický článek
Need assessment for HIV drug resistance testing and landscape of current and future technologies in low- and middle-income countries.
Autor: Parkin N; Data First Consulting, Sebastopol, CA, United States of America., Harrigan PR; Department of Medicine, University of British Columbia, Vancouver, BC, Canada., Inzaule S; Amsterdam Institute for Global Health and Development, and Department of Global Health, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Bertagnolio S; World Health Organization, Geneva, Switzerland.
Publikováno v: PLOS global public health [PLOS Glob Public Health] 2023 Oct 18; Vol. 3 (10), pp. e0001948. Date of Electronic Publication: 2023 Oct 18 (Print Publication: 2023).
Zobrazit plný text záznamu
7
Akademický článek
On-demand, hospital-based, severe acute respiratory coronavirus virus 2 (SARS-CoV-2) genomic epidemiology to support nosocomial outbreak investigations: A prospective molecular epidemiology study.
Autor: Benoit P; Department of Microbiology, Infectious Diseases and Immunology, Université de Montréal, Montréal, Québec, Canada., Jolicoeur G; Department of Medicine, Université de Montréal, Montréal, Québec, Canada., Point F; Immunopathology Axis, Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada., Soucy C; Infection Prevention and Control Service, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada., Normand K; Infection Prevention and Control Service, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada., Morency-Potvin P; Department of Microbiology, Infectious Diseases and Immunology, Université de Montréal, Montréal, Québec, Canada.; Infectious Diseases Service, Centre Hospitalier de l'Université de Montréal, Saint-Denis, Montréal, Québec, Canada., Gagnon S; Molecular Biology Service, Centre Hospitalier de l'Université de Montréal, Saint-Denis, Montréal, Québec, Canada., Kaufmann DE; Department of Medicine, Université de Montréal, Montréal, Québec, Canada.; Immunopathology Axis, Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada.; Infectious Diseases Service, Centre Hospitalier de l'Université de Montréal, Saint-Denis, Montréal, Québec, Canada., Tremblay C; Department of Microbiology, Infectious Diseases and Immunology, Université de Montréal, Montréal, Québec, Canada.; Immunopathology Axis, Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada.; Infectious Diseases Service, Centre Hospitalier de l'Université de Montréal, Saint-Denis, Montréal, Québec, Canada., Coutlée F; Department of Microbiology, Infectious Diseases and Immunology, Université de Montréal, Montréal, Québec, Canada.; Immunopathology Axis, Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada.; Infectious Diseases Service, Centre Hospitalier de l'Université de Montréal, Saint-Denis, Montréal, Québec, Canada.; Molecular Biology Service, Centre Hospitalier de l'Université de Montréal, Saint-Denis, Montréal, Québec, Canada., Harrigan PR; Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Hardy I; Department of Microbiology, Infectious Diseases and Immunology, Université de Montréal, Montréal, Québec, Canada.; Immunopathology Axis, Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada.; Molecular Biology Service, Centre Hospitalier de l'Université de Montréal, Saint-Denis, Montréal, Québec, Canada., Smith M; Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, Québec, Canada., Savard P; Department of Microbiology, Infectious Diseases and Immunology, Université de Montréal, Montréal, Québec, Canada.; Immunopathology Axis, Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada.; Infection Prevention and Control Service, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada.; Infectious Diseases Service, Centre Hospitalier de l'Université de Montréal, Saint-Denis, Montréal, Québec, Canada., Grandjean Lapierre S; Department of Microbiology, Infectious Diseases and Immunology, Université de Montréal, Montréal, Québec, Canada.; Immunopathology Axis, Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada.; Infectious Diseases Service, Centre Hospitalier de l'Université de Montréal, Saint-Denis, Montréal, Québec, Canada.; Molecular Biology Service, Centre Hospitalier de l'Université de Montréal, Saint-Denis, Montréal, Québec, Canada.
Publikováno v: Antimicrobial stewardship & healthcare epidemiology : ASHE [Antimicrob Steward Healthc Epidemiol] 2023 Mar 08; Vol. 3 (1), pp. e45. Date of Electronic Publication: 2023 Mar 08 (Print Publication: 2023).
Zobrazit plný text záznamu
8
Akademický článek
Nano-RECall provides an integrated pipeline for HIV-1 drug resistance testing from Oxford Nanopore sequence data.
Autor: Delaney KE; Division of Medical Virology, Stellenbosch University, Cape Town, South Africa., Ngobeni T; Division of Medical Virology, Stellenbosch University, Cape Town, South Africa.; Tygerberg Business Unit, National Health Laboratory Service, Cape Town, South Africa., Woods CK; University of British Columbia, Vancouver, British Columbia, Canada., Gordijn C; Division of Medical Virology, Stellenbosch University, Cape Town, South Africa., Claassen M; Division of Medical Virology, Stellenbosch University, Cape Town, South Africa.; Tygerberg Business Unit, National Health Laboratory Service, Cape Town, South Africa., Parikh U; University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Harrigan PR; University of British Columbia, Vancouver, British Columbia, Canada., van Zyl GU; Division of Medical Virology, Stellenbosch University, Cape Town, South Africa.; Tygerberg Business Unit, National Health Laboratory Service, Cape Town, South Africa.
Publikováno v: Tropical medicine & international health : TM & IH [Trop Med Int Health] 2023 Mar; Vol. 28 (3), pp. 186-193. Date of Electronic Publication: 2023 Jan 13.
Zobrazit plný text záznamu
9
Akademický článek
Genotypic correlates of resistance to the HIV-1 strand transfer integrase inhibitor cabotegravir.
Autor: Rhee SY; Division of Infectious Diseases, Department of Medicine, Stanford, CA, USA. Electronic address: syrhee@stanford.edu., Parkin N; Data First Consulting Inc., Sebastopol, CA, USA., Harrigan PR; Department of Medicine, University of British Columbia, Vancouver, Canada., Holmes S; Department of Statistics, Stanford, CA, USA., Shafer RW; Division of Infectious Diseases, Department of Medicine, Stanford, CA, USA.
Publikováno v: Antiviral research [Antiviral Res] 2022 Dec; Vol. 208, pp. 105427. Date of Electronic Publication: 2022 Sep 30.
Zobrazit plný text záznamu
10
Akademický článek
Opening the door on entry inhibitors in HIV: Redefining the use of entry inhibitors in heavily treatment experienced and treatment-limited individuals living with HIV.
Autor: Orkin C; Queen Mary University London, London, UK., Cahn P; Fundacion Huesped, Buenos Aires, Argentina.; Buenos Aires University Medical School, Buenos Aires, Argentina., Castagna A; Vita-Salute San Raffaele University, San Raffaele Scientific Institute, Milan, Italy., Emu B; Yale School of Medicine, New Haven, Connecticut, USA., Harrigan PR; University of British Columbia, Vancouver, BC, Canada., Kuritzkes DR; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Nelson M; Chelsea and Westminster Hospital, London, UK., Schapiro J; Sheba Medical Center, Tel Aviv, Israel.
Publikováno v: HIV medicine [HIV Med] 2022 Oct; Vol. 23 (9), pp. 936-946. Date of Electronic Publication: 2022 Mar 16.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje